Mandy Yeung
About Mandy Yeung
Mandy Yeung serves as the Head of Market Access Marketing & Strategy at BridgeBio, bringing over 18 years of experience in the biotech industry. Her career spans various roles, including leadership positions at Genentech and BridgeBio, and she has a strong focus on advancing treatments for cancer and other serious diseases.
Current Role at BridgeBio
Mandy Yeung currently serves as the Head of Market Access Marketing & Strategy at BridgeBio. She has held this position since 2023. In her role, she focuses on developing strategies that enhance market access for the company's products, ensuring that they reach the patients who need them. Her extensive background in the biotech industry supports her efforts in this capacity.
Previous Experience at BridgeBio
Prior to her current role, Mandy Yeung worked at BridgeBio as the Senior Director of Business Development & Operations in Alliance Management for Eidos Therapeutics in 2023. She also served as Director in the same department from 2021 to 2023. Her experience at BridgeBio has contributed to her expertise in alliance management and strategic operations within the biotech sector.
Experience at Genentech
Mandy Yeung has significant experience at Genentech, where she held multiple roles over several years. Her positions included Associate Director of Healthcare Delivery Innovation Partnership Execution, National Account Executive, and various strategy and finance roles. Her tenure at Genentech spanned from 2005 to 2021, providing her with a comprehensive understanding of the biotech landscape.
Educational Background
Mandy Yeung earned her Bachelor of Science in Molecular Biology from the Massachusetts Institute of Technology (MIT), where she studied from 2001 to 2005. She later obtained her MBA from the MIT Sloan School of Management, completing her studies from 2011 to 2013. Her educational background has equipped her with both scientific knowledge and business acumen.
Career Development and Focus
Mandy Yeung has over 18 years of experience in the biotech industry, with a career driven by a mission to contribute to the business of curing cancer and other life-threatening diseases. She has transitioned from a healthcare consultant to a market access leader, demonstrating her ability to blend scientific knowledge with business strategy. Her early career experiences in a cancer lab have influenced her professional trajectory.